California Cancer Reporting System Standards, Volume III

IF1221: TNM T, Descriptor, SSF 1 Thyroid (COC)

OWNER

CoC

EDIT SETS

California Hospital Transmit

Eureka Admission Level

Eureka Tumor Level

FIELDS

TNM Clin T [NAACCR #940]

TNM Path T [NAACCR #880]

TNM Clin Descriptor [NAACCR #980]

TNM Path Descriptor [NAACCR #920]

CS Site-Specific Factor 1 [NAACCR #2880]

Primary Site [NAACCR #400]

Date of Diagnosis [NAACCR #390]

Type of Reporting Source [NAACCR# 500]

Histologic Type ICD-O-3 [NAACCR #522]

Behavior Code ICD-O-3 [NAACCR# 523]

TABLE

N/A

MESSAGE

1. IF1221: Conflict among CS Site-Specific Factor 1 [value], TNM Clin Descriptor [value] and TNM Path Descriptor [value]

specification

Purpose: This edit verifies that CS Site-Specific Factor 1 (Solitary vs Multifocal Tumor) is coded consistently with TNM Clin Descriptor and TNM Path Descriptor for Thyroid.

This edit is skipped if any of the following conditions are true:

1. Year of Date of Diagnosis is less than 2016, blank (unknown), or invalid

2. Type of Reporting Source = 7 (Death Certificate Only)

3. Behavior Code ICD-O-3 = 0 (benign) or 1 (borderline)

4. Site/histology group is not 08A-F (thyroid)

5. TNM Clin T and TNM Path T are blank or 88

6. CS SSF 1 is blank or 988

7. TNM Clin Descriptor and TNM Path Descriptor are blank

8. TNM Edition Number not = 07, U7

The site/histology groups are identified by site and histology in the edit Primary Site, Stage Group 2016 - Ed 7.

For Thyroid:

1. If CS SSF 1 = 010 (Solitary tumor), then TNM Clin Descriptor or TNM Path Descriptor must = 0 (none).
   

2. If CS SSF 1 = 020,( Multifocal tumor), then TNM Clin Descriptor must = 3 (M, multiple primary tumors in a single site) or TNM Path Descriptor must = 3 (M, multiple primary tumors in a single site) or 6 (M&Y, multiple primary tumors and initial multimodality therapy).
   

3. If TNM Clin Descriptor and TNM Path Descriptor = 0 (none) then CS SSF 1 must = 010 (Solitary tumor).
   

4. If TNM Clin Descriptor = 3 (Multiple primary tumors in a single site) and TNM Path Descriptor = 3 (multiple tumors in a single site) or 6 (Multiple primary tumors and initial multimodality therapy) then CS SSF 1 must = 020 (Multifocal tumor).

historical changes